Cargando…
miRNA Delivery by Nanosystems: State of the Art and Perspectives
MicroRNAs (miRNAs) are short (~21–23 nucleotides), non-coding endogenous RNA molecules that modulate gene expression at the post-transcriptional level via the endogenous RNA interference machinery of the cell. They have emerged as potential biopharmaceuticals candidates for the treatment of various...
Autores principales: | Moraes, Fernanda C., Pichon, Chantal, Letourneur, Didier, Chaubet, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619868/ https://www.ncbi.nlm.nih.gov/pubmed/34834316 http://dx.doi.org/10.3390/pharmaceutics13111901 |
Ejemplares similares
-
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
por: Cai, Lisha, et al.
Publicado: (2022) -
Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
por: Silva, Amanda Karine Andriola, et al.
Publicado: (2014) -
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2021) -
Polymeric Nanosystems Applied for Metal-Based Drugs and Photosensitizers Delivery: The State of the Art and Recent Advancements
por: Dantas, Kele Cristina Ferreira, et al.
Publicado: (2022) -
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
por: Nagachinta, Surasa, et al.
Publicado: (2020)